Drug intelligence / Profile preview

Desirial Plus

Development stage
Unknown
Lead developer
Laboratoires Vivacy
Administration
Subcutaneous
01

Overview

Desirial Plus is a sterile, injectable gel medical device developed by Laboratoires VIVACY, primarily used in aesthetic and functional gynecology. It is composed of cross-linked hyaluronic acid and mannitol, formulated using the proprietary Inter-Penetrated Cross-linked Networks (IPN)-like technology. The product is specifically indicated for the treatment of moderate to severe hypotrophy or atrophy of the labia majora and vulva, as well as vulvovaginal dryness and associated discomfort. By acting as a volumizing and hydrating agent within the extracellular matrix of vulvovaginal tissues, it restores volume and improves tissue hydration. It is also utilized to enhance the aesthetic appearance of the labia majora and has applications in addressing female sexual dysfunction. The gel is administered via subcutaneous injection by healthcare professionals, with clinical effects typically lasting up to 12 months.

Brand names
Desirial Plus
Other names
Desirial Plus

Beyond the preview

Go deeper on Desirial Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Desirial Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call